Viewing nowAvatin 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Hwa-il Pharmaceutical Co., Ltd.

MFDS item code 201401233 · Approved 2014.03.18 · Insurance code 684501040
Reduction of the risk of myocardial infarction and stroke, improvement of hypercholesterolemia
This medication helps reduce the risk of cardiovascular diseases. It reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, it lowers the risk of various cardiovascular complications such as myocardial infarction, stroke, congestive heart failure, and angina. In patients with hyperlipidemia, it is used to reduce total cholesterol and LDL cholesterol levels while increasing HDL cholesterol levels to improve the lipid profile. It is particularly effective in treating patients with dyslipidemia who do not respond to dietary changes or those with homozygous familial hypercholesterolemia. Furthermore, it is also utilized in treating hypercholesterolemia in pediatric patients aged 10 to 17 who meet certain conditions. This medication is used to reduce the risk of cardiovascular diseases and improve blood lipid levels.
For hyperlipidemia, the recommended starting dose is 10 mg of atorvastatin once daily; for patients requiring more LDL cholesterol reduction, treatment can be started at 20 mg or 40 mg once daily. This medication is administered in a dosage range of 10 to 80 mg once daily. Dosing must be individualized based on treatment goals and patient response, and lipid levels should be assessed 2 to 4 weeks after initiation or dose adjustment.
For pediatric patients (ages 10-17) with heterozygous familial hypercholesterolemia, the recommended starting dose is 10 mg once daily, and the recommended maximum dose is 20 mg once daily. Dosage adjustments should be made at intervals of 4 weeks or more based on treatment objectives.
This medication may cause muscle problems, and if myalgia or muscle weakness becomes severe, or if creatine kinase (CK) levels rise significantly, use should be stopped immediately. Patients with poor liver function or liver disease should not use this medication and should undergo regular liver function tests. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It is safest not to use in children, especially those under 10 years of age. Caution should be exercised in patients with alcohol dependence or a history of liver disease, renal impairment, and hypothyroidism, and monitoring for muscle-related side effects is necessary. This medication can interact with other drugs; therefore, patients taking certain antibiotics, antifungals, antivirals, immunosuppressants, antihypertensives, or antidiabetic medications should inform their doctor or pharmacist. If symptoms such as myalgia, weakness, or fever occur during treatment, patients should immediately inform healthcare professionals, and blood tests may be necessary to check for muscle damage. This medication may cause liver function abnormalities, skin rashes, allergic reactions, gastrointestinal symptoms, headaches, and dizziness; if symptoms are severe or persistent, patients should consult with healthcare professionals. Elderly patients or those with renal disorders are at higher risk for myopathy and should be monitored closely. There is no specific antidote for overdose, so treatment should be conducted based on symptoms, and liver function and muscle status should be monitored. Keep this medication out of the reach of children and store it in its original container.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain of oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, disorientation, visual disturbances, paralysis, urinary changes
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to protect it from air and moisture, at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Hwa-il Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.